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To the Editor 
 
February 29th is officially marked as “Rare Disease Day”. Hitherto, over 5,800 rare diseases 
were officially recognized, but not a single adult psychiatric disorder. This leap year for the first 
time postpartum psychosis is included in the list curated by Orphanet, the reference portal for 
information on rare diseases.  
Postpartum psychosis is one of the most severe and dramatic psychiatric illnesses. It is 
characterized by the abrupt onset of psychiatric and often neurological symptoms, mostly in the 
first two weeks postpartum. It affects mainly women without any medical history and is therefore 
very difficult to predict. The incidence is very low, 0.25-0.5 per 1000 deliveries, but the relative 
risk for the first onset of affective psychosis is 23 times higher postpartum than at any other 
period1.  
If promptly and  adequately treated, the short term prognosis is promising2. The risk for a 
disabling life-long disease (such as bipolar disorder) and for recurrence after a next pregnancy3 
are however high. Postpartum psychosis is also associated with an increased risk of infanticide4 
and suicide5, a leading cause of maternal death.  
Postpartum psychosis is an orphan (from Indo-European orbh, bereft) disease not only because 
it is rare, but also because it lacks an official recognition. The uncertainties on its definition and 
classification have probably prevented consistent conclusions on its pathophysiology and 
management. Postpartum psychosis nevertheless represents a unique opportunity for 
psychiatry: in no other situation it is possible to so precisely define the moment of onset. The 
specific and close relationship with delivery offers the possibility of prevention, and, more 
generally, of a better understanding of the impact of hormones and the immune system on the 
brain. 
The inclusion of postpartum psychosis in the list of rare disorders is an important recognition for 
the women affected, their families and the entire psychiatric community. First, it reduces the 
stigma, by offering an official medical status, promoting scientific information and linking patients 
and their families with organizations and expert centers. Second, it helps to optimize research 
efforts by offering a list of ongoing research projects and data repositories, facilitating 
collaborations and communication between researchers and specialized centres. Finally, as a 
substantial proportion of women with postpartum psychosis who commit suicides or infanticide 
were misdiagnosed and therefore did not receive adequate treatment4,5, we also hope that the 
recognition as a severe, rare disorder will help contrasting the tendency of labelling it as 
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